| Name | Lincare Inc |
|---|---|
| Organization Name | Lincare Inc |
| Location | 1609 32nd Ave S, Ste C, Fargo, North Dakota 58103 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (701) 235-0175 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data from a landmark study.Paul Whelton, MB, MD, MSc, reported the results on Aug. 13 at the plenary session of the China Heart Congress and International Heart Forum in Beijing. Whelton is president and CEO of Loyola University Health System and chairman of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heat Attack Trial (ALLHAT), which has examined the comparative value of different blood pressure-lowering medications.
While the rest of the world is keeping its distance from the mosquito that carries the Zika virus, two New Mexico State University professors are seeking out this mosquito, which carries not only Zika but also a host of other diseases as well.
Technologies to capture and view clinical trial data in real time offer great potential to enhance patient safety, strengthen trial quality and accelerate drug development, but they also require new guidelines to ensure trial integrity, according to the white paper "Using Real-Time Data to Drive Better Decisions, Faster" released today by Quintiles, the world's leading biopharmaceutical services company.
Imagine a mosquito-borne virus that has already infected millions of people in recent outbreaks in South and Southeast Asia, the islands of the Indian Ocean, Africa and northern Italy. Although seldom fatal, it causes highly painful arthritis-like symptoms that can linger for months or even years. It's capable of adapting to spread through a mosquito species common in much of North America. And no vaccine or treatment exists to protect humans from its effects.
In a new study, the role of a coronavirus-specific protein domain in SARS-CoV-2 viral synthesis initiation is investigated, and potential therapeutic solutions have been explored.
› Verified 9 days ago
| NPI Number | 1831263185 |
| Organization Name | LINCARE INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1609 32nd Ave S, Ste C, Fargo, ND 58103 |
| Phone Number | 701-235-0175 |
News Archive
Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data from a landmark study.Paul Whelton, MB, MD, MSc, reported the results on Aug. 13 at the plenary session of the China Heart Congress and International Heart Forum in Beijing. Whelton is president and CEO of Loyola University Health System and chairman of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heat Attack Trial (ALLHAT), which has examined the comparative value of different blood pressure-lowering medications.
While the rest of the world is keeping its distance from the mosquito that carries the Zika virus, two New Mexico State University professors are seeking out this mosquito, which carries not only Zika but also a host of other diseases as well.
Technologies to capture and view clinical trial data in real time offer great potential to enhance patient safety, strengthen trial quality and accelerate drug development, but they also require new guidelines to ensure trial integrity, according to the white paper "Using Real-Time Data to Drive Better Decisions, Faster" released today by Quintiles, the world's leading biopharmaceutical services company.
Imagine a mosquito-borne virus that has already infected millions of people in recent outbreaks in South and Southeast Asia, the islands of the Indian Ocean, Africa and northern Italy. Although seldom fatal, it causes highly painful arthritis-like symptoms that can linger for months or even years. It's capable of adapting to spread through a mosquito species common in much of North America. And no vaccine or treatment exists to protect humans from its effects.
In a new study, the role of a coronavirus-specific protein domain in SARS-CoV-2 viral synthesis initiation is investigated, and potential therapeutic solutions have been explored.
› Verified 9 days ago
News Archive
Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data from a landmark study.Paul Whelton, MB, MD, MSc, reported the results on Aug. 13 at the plenary session of the China Heart Congress and International Heart Forum in Beijing. Whelton is president and CEO of Loyola University Health System and chairman of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heat Attack Trial (ALLHAT), which has examined the comparative value of different blood pressure-lowering medications.
While the rest of the world is keeping its distance from the mosquito that carries the Zika virus, two New Mexico State University professors are seeking out this mosquito, which carries not only Zika but also a host of other diseases as well.
Technologies to capture and view clinical trial data in real time offer great potential to enhance patient safety, strengthen trial quality and accelerate drug development, but they also require new guidelines to ensure trial integrity, according to the white paper "Using Real-Time Data to Drive Better Decisions, Faster" released today by Quintiles, the world's leading biopharmaceutical services company.
Imagine a mosquito-borne virus that has already infected millions of people in recent outbreaks in South and Southeast Asia, the islands of the Indian Ocean, Africa and northern Italy. Although seldom fatal, it causes highly painful arthritis-like symptoms that can linger for months or even years. It's capable of adapting to spread through a mosquito species common in much of North America. And no vaccine or treatment exists to protect humans from its effects.
In a new study, the role of a coronavirus-specific protein domain in SARS-CoV-2 viral synthesis initiation is investigated, and potential therapeutic solutions have been explored.
› Verified 9 days ago
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1609 32nd Ave S, Fargo, North Dakota 58103 Phone: (701) 235-0175 | |
Partner Medical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5256 50th Ave S, Fargo, North Dakota 58104 Phone: (701) 356-4813 | |
The Medicine Shoppe Type: Pharmacy Location: 2800 Broadway N, Fargo, North Dakota 58102 Phone: (701) 293-0221 | |
Cvs Pharmacy #08612 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2425 13th Ave S, Fargo, North Dakota 58103 Phone: (701) 232-4872 | |
Cvs Pharmacy #08613 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1321 19th Ave N, Fargo, North Dakota 58102 Phone: (701) 232-2720 |